Efficacy and safety of obinutuzumab in patients with primary membranous nephropathy: a focus on refractory and rituximab-resistant patients - Quiz - MDSpire

Efficacy and safety of obinutuzumab in patients with primary membranous nephropathy: a focus on refractory and rituximab-resistant patients

  • By

  • Qi Gao

  • Guoxiang Yao

  • Yujiao Sun

  • Xiaoyun Li

  • Zhuo Li

  • Bing Chen

  • June 26, 2026

  • 0 min

Share

Original Source(s)

Efficacy and safety of obinutuzumab in patients with primary membranous nephropathy: a focus on refractory and rituximab-resistant patients

  • by Qi Gao, Guoxiang Yao, Yujiao Sun, Xiaoyun Li, Zhuo Li, Bing Chen

  • June 26, 2026

Related Content

Systemic lupus erythematosus associated with paroxysmal nocturnal hemoglobinuria: a case report and literature review highlighting the clinical significance of small PNH clones

Lipid changes after interleukin-6 blockade in rheumatoid arthritis: beyond cholesterol elevation toward hepatic inflammatory-lipoprotein remodeling

Case Report: Dupilumab as a corticosteroid-sparing adjunct in severe mucocutaneous pemphigus vulgaris with prior avascular necrosis and chronic kidney disease